Investigating the Roles of MAPKs as Precision Oncology Targets: A Multi-cancer Expression and Survival Study
Our integrated approach underscores the value of MAPK family members as both biomarkers and therapeutic targets in LIHC and LUAD. This study contributes important insights into MAPK-related oncogenic processes and supports the development of targeted therapies under the framework of precision oncology.
Authors
- Sobia Zaidi (ORCID: https://orcid.org/0000-0003-0289-6413)
- Prithvi Singh (ORCID: https://orcid.org/0000-0002-2562-0914)
- Ravins Dohare (ORCID: https://orcid.org/0000-0002-0602-3719)
- Md Nayab Sulaimani
- Afzal Hussain (ORCID: https://orcid.org/0000-0002-6275-5375)
- Mohamed F. Alajmi (ORCID: https://orcid.org/0000-0002-3044-1267)
- Md. Imtaiyaz Hassan (ORCID: https://orcid.org/0000-0002-3663-4940)
- A. Shamsi
- Mohammad Umar Saeed (ORCID: https://orcid.org/0000-0002-2052-5934)
Institutions
- Ajman University (AE)
- King Saud University (SA)
- Jamia Millia Islamia (IN)
Publication Details
- Journal
- Cancer Genomics & Proteomics
- Published
- 2025-10-28
- DOI
- https://doi.org/10.21873/cgp.20552
- Primary Topic
- Melanoma and MAPK Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Indian Council of Medical Research
- Council of Scientific and Industrial Research, India
- King Saud University